Prediction Not checkable as stated
Anderson claims she is confident she will never develop Alzheimer's disease
“I tell people I can confidently say I will never develop Alzheimer's.”
Assertion Contradicted
Anderson: KiHealth validated liquid biopsy detecting diabetes two years before symptoms
“And we just clinically validated the first liquid biopsy test that can identify diabetes two years before you're symptomatic.”
Assertion Not checkable as stated
A plant-based therapeutic demonstrated 75% efficacy compared to synthetic GLP-1s
“And in a head-to-head study, it had 75% efficacy comparative to GLP ones, which are obviously artificial.”
Insight
Anderson: Physicians are trained for reactive guidelines, not proactive prevention
“These physicians are trained a certain way. They're not trained to focus on prevention. They're trained to follow the guidelines that our health system has put in place, which are very rigorous and they're reactive. They're not proactive.”
Assertion Not checkable as stated
Anderson: Health insurance payers never cover prevention by mandate
“If you ask most payers, payers will tell you they don't ever cover prevention. It's not even in their mandate.”
Insight
Anderson: University venture arms demand equal effort for much smaller checks
“You're going to invest the same amount of time to get money out of the venture arm of a university that you would be to go to a family office or a wealthy philanthropist and get checks for a half a million or a million dollars.”
Insight
Anderson: Epigenetics matters more than baseline genetics for health outcomes
“Genetics. I don't want to say they don't matter, but they're not the decision maker. What really matters is epigenetics. It's what you're expressing. It's what's going on in your environment that's activating those genes. In a positive or negative way.”
Insight
Anderson: Diagnostic tests should optimize cellular health before disease progression
“Really what these tests should be doing is telling you how to be well, how to optimize your health at a cellular level and looking at diseases before they progress.”
Insight
Anderson: Academic lab validation does not prove commercial diagnostic viability
“Just because it works in a university lab, it does not mean it's commercially viable. And I think that's the thing people will be like, oh, it's validated. It worked in a university lab. And I'm like, that's just cause you can do one sample in a three day proc…”
Insight
Anderson: Biotech founders mistakenly expect commercialization in three years instead of five
“I think the entrepreneurial mistake is always, I'm going to be commercial in three years and in reality it's going to be five.”
Assertion Supported
Anderson: No direct biomarker exists today for type 1 diabetes development
“What most people don't realize is there is currently no direct biomarker for measurement of the development of type one.”
Assertion Contradicted
Anderson: Half of the US population lacks a primary care provider
“50% of the U.S. Population does not have a primary care provider, so they're not even going to the doctor. They're not getting regular checkups.”
Assertion Supported
Anderson: Most type 2 diabetes patients lose half their beta cells before diagnosis
“And why that's so important is today, at the time of somebody being diagnosed with type two diabetes, in most cases, half of their beta cells are already gone.”
Disclosure
Anderson: KiHealth is developing an early detection test for pancreatic cancer
“In our pipeline, we have a test for pancreatic cancer that we're developing.”
Insight
Anderson: Metabolic regulation, low inflammation, and gut health are health's core pillars
“If you want to be healthy, there's only really three things you need to think about. Metabolic health. So are you metabolically regulated? Do you have low inflammation? And are, do you have a healthy gut? If you have a healthy gut, low inflammation, you're met…”
Disclosure
Anderson: All KiHealth tests are FSA/HSA eligible with a sub-$300 target
“All of our tests are FSA, HSA eligible, and our goal is to have all of the tests under 300 dollars”
Assertion Not checkable as stated
Anderson: KiHealth Analyzes 20,000 Components Per Blood Sample in a Day
“Essentially we're taking your one ml of blood, which is not very much, and we're breaking it up into 20,000 different components, and then we're analyzing each one of those 20,000 components individually. So the process itself takes almost an entire day to ana…”
Assertion Not checkable as stated
Yale's 17-hour assay protocol delayed KiHealth's clinical validation by nine months
“It took us about nine months longer than we anticipated to get through all of the clinical validation because What we realized halfway through was we could validate the method that Yale did, and we could validate it in a commercial setting, but the method wasn…”
Insight
Anderson: Private healthcare payers follow CMS before agreeing to diagnostic coverage
“What most people don't realize is private payers follow CMS. So you pretty much have to go to CMS first. They have to say, yes, you're legitimate. Yes, we want to work with you. Yes, we want to cover you. And the private payers go, okay, well, they did all the…”
